Cytek Biosciences (CTKB) Short-term Investments (2020 - 2024)

Cytek Biosciences (CTKB) has 4 years of Short-term Investments data on file, last reported at $29000.0 in Q4 2024.

• Quarterly Short-term Investments fell 91.24% year-over-year to $29000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $29000.0 (down 91.24% YoY) and the FY2024 annual result came in at $29000.0, down 91.24% from the prior year.
• Short-term Investments eased to $29000.0 in Q4 2024, from $31000.0 in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $2.9 million in Q1 2023 to a low of $29000.0 in Q4 2024.
• A 4-year average of $940750.0 and a median of $365500.0 in 2023 frame the typical range for Short-term Investments.
• The widest YoY moves for Short-term Investments: up 86.29% in 2024, down 91.24% in 2024.
• Tracing CTKB's Short-term Investments over 4 years: stood at $888000.0 in 2020, then surged by 226.46% to $2.9 million in 2022, then tumbled by 88.58% to $331000.0 in 2023, then tumbled by 91.24% to $29000.0 in 2024.
• The last three Short-term Investments figures came in at $29000.0 (Q4 2024), $31000.0 (Q3 2024), and $30000.0 (Q2 2024), per Business Quant data.